This course has been made available through a partnership between the New York University College of Dentistry and the New York State Dental Foundation.
DETECTING & MANAGING ORAL PRECANCER AND CANCER
Since all oral cancers start out as oral precancer or dysplasia, the dental health professional can improve patient outcome by appropriately managing oral dysplasia in their practice. Early diagnosis of oral cancer significantly impacts on both treatment and survival. This course covers the current epidemiology of oral cancer (including information related to HPV+ oropharyngeal cancers), the clinical features that are suggestive of oral cancer and potentially malignant oral lesions, the indications for emerging adjunctive diagnostic techniques (imaging, tissue autofluorescence, toluidine blue staining, cytopathologic techniques, and HPV testing), and provide the participants with an update on the management of patients diagnosed with epithelial dysplasia and oral cancer. Clinical cases are used in this course to highlight topic.
At the completion of this course you will understand:
the epidemiologic shift in the demographics and risk factors for oral cancer
the clinical features suggestive of oral cancer and potentially malignant oral lesions
new methods of detection and mapping of oral cancer and epithelial dysplasia
current management strategies for oral cancer and epithelial dysplasia
Course Benefits for Oral and Maxillofacial Surgeons include:
Brian Schmidt, DDS, MD. PhD, FACS, is a professor and NYU College of Dentistry in the Department of Oral & Maxillofacial Surgery, and Director of the Bluestone Center for Clinical Research at NYU College of Dentistry.
A. Ross Kerr, DDS, MSD, is an associate professor in the Department of Oral & Maxillofacial Pathology, Radiology and Medicine at NYU College of Dentistry.